Search by Drug Name or NDC

NDC 43975-0323-50 Tolterodine Tartrate 4 mg/1 Details

Tolterodine Tartrate 4 mg/1

Tolterodine Tartrate is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ANI Pharmaceuticals, Inc.. The primary component is TOLTERODINE TARTRATE.

MedlinePlus Drug Summary

Tolterodine is used treat overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Tolterodine is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles preventing bladder contraction.

Related Packages: 43975-0323-50
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Tolterodine

Product Information

NDC	43975-0323
Product ID	43975-323_ba54a9d0-25e3-406f-b721-58e4fa2d8cb0
Associated GPIs	54100060207030
GCN Sequence Number	047327
GCN Sequence Number Description	tolterodine tartrate CAP ER 24H 4 MG ORAL
HIC3	R1A
HIC3 Description	URINARY TRACT ANTISPASMODIC/ANTIINCONTINENCE AGENT
GCN	12263
HICL Sequence Number	018047
HICL Sequence Number Description	TOLTERODINE TARTRATE
Brand/Generic	Generic
Proprietary Name	Tolterodine Tartrate
Proprietary Name Suffix	n/a
Non-Proprietary Name	Tolterodine Tartrate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	4
Active Ingredient Units	mg/1
Substance Name	TOLTERODINE TARTRATE
Labeler Name	ANI Pharmaceuticals, Inc.
Pharmaceutical Class	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA204562
Listing Certified Through	2024-12-31

Package

NDC 43975-0323-50 (43975032350)

Pricing Information	N/A
NDC Package Code	43975-323-50
Billing NDC	43975032350
Package	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43975-323-50)
Marketing Start Date	2019-08-29
NDC Exclude Flag	N